R. Hall

1.1k total citations
32 papers, 860 citations indexed

About

R. Hall is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Urology. According to data from OpenAlex, R. Hall has authored 32 papers receiving a total of 860 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Surgery, 9 papers in Pulmonary and Respiratory Medicine and 6 papers in Urology. Recurrent topics in R. Hall's work include Bladder and Urothelial Cancer Treatments (18 papers), Urinary and Genital Oncology Studies (13 papers) and Urological Disorders and Treatments (6 papers). R. Hall is often cited by papers focused on Bladder and Urothelial Cancer Treatments (18 papers), Urinary and Genital Oncology Studies (13 papers) and Urological Disorders and Treatments (6 papers). R. Hall collaborates with scholars based in United Kingdom, Belgium and Netherlands. R. Hall's co-authors include Mahesh Parmar, Philip H. Smith, James L. Reading, David E. Neal, Adrian L. Harris, Kieran Smith, Janet A. Fennelly, Aldo Bono, A.P.M. van der Meijden and R. Sylvester and has published in prestigious journals such as The Lancet, SHILAP Revista de lepidopterología and The Journal of Urology.

In The Last Decade

R. Hall

31 papers receiving 797 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
R. Hall United Kingdom 16 620 214 185 144 132 32 860
Wolfgang Hoeltl Austria 11 1.1k 1.7× 370 1.7× 168 0.9× 287 2.0× 174 1.3× 20 1.2k
Dallas Williams United States 12 700 1.1× 227 1.1× 252 1.4× 131 0.9× 86 0.7× 24 966
Geralyn Higgins United States 8 914 1.5× 85 0.4× 271 1.5× 251 1.7× 99 0.8× 10 996
Joseph T. Leimert United States 7 872 1.4× 329 1.5× 175 0.9× 88 0.6× 159 1.2× 8 994
Justin T. Matulay United States 16 598 1.0× 198 0.9× 107 0.6× 222 1.5× 129 1.0× 62 773
Eugene J. Pietzak United States 15 655 1.1× 109 0.5× 182 1.0× 219 1.5× 254 1.9× 89 869
F. Desgrandchamps France 11 184 0.3× 97 0.5× 141 0.8× 129 0.9× 97 0.7× 25 514
J. Leißner Germany 15 1.1k 1.8× 570 2.7× 196 1.1× 239 1.7× 98 0.7× 36 1.3k
A. Garbeglio Italy 13 740 1.2× 279 1.3× 211 1.1× 451 3.1× 137 1.0× 27 1.2k
W. Höltl Austria 16 834 1.3× 120 0.6× 58 0.3× 262 1.8× 309 2.3× 47 1.0k

Countries citing papers authored by R. Hall

Since Specialization
Citations

This map shows the geographic impact of R. Hall's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Hall with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Hall more than expected).

Fields of papers citing papers by R. Hall

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. Hall. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Hall. The network helps show where R. Hall may publish in the future.

Co-authorship network of co-authors of R. Hall

This figure shows the co-authorship network connecting the top 25 collaborators of R. Hall. A scholar is included among the top collaborators of R. Hall based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. Hall. R. Hall is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Richards, Rebecca, et al.. (2025). Semaglutide and Tirzepatide in a Remote Weight Management Program: 12-Month Retrospective Observational Study. JMIR Formative Research. 9. e81912–e81912. 1 indexed citations
2.
Hall, R., et al.. (2023). High grade phyllodes tumor with osteosarcomatous differentiation: Case report and review of the literature. SHILAP Revista de lepidopterología. 18(9). 3127–3134. 1 indexed citations
3.
Oosterlinck, W., et al.. (2001). Frequency of Positive Biopsies after Visual Disappearance of Superficial Bladder Cancer Marker Lesions. European Urology. 40(5). 515–517. 13 indexed citations
4.
Palou, Joan, et al.. (2001). CONTROL GROUP AND MAINTENANCE TREATMENT WITH BACILLUS CALMETTE-GUERIN FOR CARCINOMA IN SITU AND/OR HIGH GRADE BLADDER TUMORS. The Journal of Urology. 1488–1491. 4 indexed citations
5.
Jakse, G., R. Hall, Aldo Bono, et al.. (2001). Intravesical BCG in Patients with Carcinoma in situ of the Urinary Bladder: Long–Term Results of EORTC GU Group Phase II Protocol 30861. European Urology. 40(2). 144–150. 66 indexed citations
6.
Curran, Desmond, et al.. (1997). Baseline quality of life of patients with advanced prostate cancer. European Journal of Cancer. 33(11). 1809–1814. 50 indexed citations
8.
Meijden, A.P.M. van der, R. Hall, K. H. Kurth, Ch. Bouffioux, & R. Sylvester. (1996). Phase II trials in Ta, T1 bladder cancer. The marker tumour concept. British Journal of Urology. 77(5). 634–637. 43 indexed citations
9.
Bono, Aldo, et al.. (1996). Chemoresection in Ta-T1 Bladder Cancer. European Urology. 29(4). 385–390. 43 indexed citations
10.
Koiso, Kenkichi, William U. Shipley, F. Keuppens, et al.. (1995). THE STATUS OF BLADDER‐PRESERVING THERAPEUTIC STRATEGIES IN THE MANAGEMENT OF PATIENTS WITH MUSCLE‐INVASIVE BLADDER CANCER. International Journal of Urology. 2(s2). 49–57. 11 indexed citations
11.
Reading, James L., R. Hall, & Mahesh Parmar. (1995). The application of a prognostic factor analysis for Ta.T1 bladder Cancer in routine urological practice. British Journal of Urology. 75(5). 604–607. 37 indexed citations
12.
Hall, R., et al.. (1995). The persistence of bacille Calmette‐Guerin in the bladder after intravesical treatment for bladder cancer. British Journal of Urology. 75(2). 188–192. 56 indexed citations
14.
15.
Hall, R.. (1994). Current Issues in Cancer: Superficial bladder cancer. BMJ. 308(6933). 910–913. 6 indexed citations
16.
Hall, R., et al.. (1991). Systemic Chemotherapy for Urothelial Cancer in Patients with Ureteric Obstruction. British Journal of Urology. 67(2). 169–172. 4 indexed citations
17.
Richards, B., Malin Parmar, C. K. Anderson, et al.. (1991). Interpretation of Biopsies of “Normal” Urothelium in Patients with Superficial Bladder Cancer. British Journal of Urology. 67(4). 369–375. 38 indexed citations
18.
Kurth, K. H., F M Debruyne, R. Hall, et al.. (1987). Embolization and Postinfarction Nephrectomy in Patients withPrimary Metastatic Renal Adenocarcinoma. European Urology. 13(4). 251–255. 8 indexed citations
19.
Hall, R.. (1982). Report to the Standing Committee on Urological Instruments: Lasers in Urology. British Journal of Urology. 54(4). 421–426. 7 indexed citations
20.
Hall, R., et al.. (1976). Randomized comparison of melphalan and 5-fluorouracil in the treatment of advanced gastrointestinal cancer.. PubMed. 60(9). 1267–71. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026